Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Port Site Bupivacaine for Pain After Laparoscopic Cholecystectomy
NCT05264805Phase 3Unknown
- Sponsor
- Hamdard University
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Hamdard University. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05264805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264805.